Abstract
Pharmacological treatment of alcohol use disorder represents an essential core of the therapeutic project in a multidisciplinary approach. While non-drug treatment is evolving, from a medical perspective few pharmacotherapies are available; in particular acamprosate, naltrexone and more recently nalmefene among anticraving drugs, disulfiram as an antidipsotropic medication. New studies are focusing on off-label drugs. Moreover, scientific evidence has to support any therapeutic indication which should be tailored on patient needs and comorbidity by considering the individual bio-psycho-social profile. Follow-up is essential in order to assess patient compliance to treatment and monitoring outcomes.
Original language | English |
---|---|
Pages (from-to) | 123-127 |
Number of pages | 5 |
Journal | Rivista di Psichiatria |
Volume | 53 |
Issue number | 3 |
DOIs | |
Publication status | Published - Jun 19 2018 |
Keywords
- Acamprosate/therapeutic use
- Alcohol Deterrents/therapeutic use
- Alcoholism/drug therapy
- Baclofen/therapeutic use
- Disulfiram/therapeutic use
- Drug Evaluation
- Humans
- Naltrexone/analogs & derivatives
- Off-Label Use
- Olanzapine/therapeutic use
- Ondansetron/therapeutic use
- Sertraline/therapeutic use
- Sodium Oxybate/therapeutic use
- Topiramate/therapeutic use
- Varenicline/therapeutic use